Literature DB >> 1653636

Biochemical characterization and regional quantification of mu, delta and kappa opioid binding sites in rat spinal cord.

C W Stevens1, C B Lacey, K E Miller, R P Elde, V S Seybold.   

Abstract

The spinal cord contains mu, delta and kappa opioid receptors which mediate the antinociceptive effects of opioid agonists administered onto the spinal cord. In this study, we characterized the binding sites for highly-selective mu, delta and kappa opioid radioligands and quantified the distribution of opioid binding sites in rat lumbosacral spinal cord using autoradiography. In sections of rat brain mounted on glass slides, the mu ligand, [3H]sufentanil, bound with high affinity with an apparent Kd of 0.46 nM. The delta ligand, [3H]DPDPE [( D-Pen2.5]-enkephalin), bound with a Kd of 4.31 nM, and the kappa-ligand, [3H]U69593, bound with a Kd of 2.27 nM. Three regions of the spinal gray were targeted for quantification of binding sites by autoradiography. The data indicate that when considered as a percentage of the total opioid binding capacity within a region, the contribution of mu sites in laminae I-II was about 90%, with delta and kappa sites 7% and 3%, respectively. In lamina V, the mu sites comprised about 70% of the total opioid sites, with delta and kappa sites comprising 28% and 2%, respectively. In the area adjacent to the central canal, mu sites contributed about 65% of the total opioid sites followed by delta sites at 33% and kappa sites at 2% of total opioid sites. These results demonstrate a differential distribution of mu, delta and kappa binding sites with respect to the organization of the spinal gray matter. The preferential occurrence of all 3 opioid binding sites in the superficial dorsal horn is noteworthy since many fine caliber primary afferent fibers mediating nociception establish synaptic contact in this region.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653636     DOI: 10.1016/0006-8993(91)90407-m

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Actions of opioids on excitatory and inhibitory transmission in substantia gelatinosa of adult rat spinal cord.

Authors:  T Kohno; E Kumamoto; H Higashi; K Shimoji; M Yoshimura
Journal:  J Physiol       Date:  1999-08-01       Impact factor: 5.182

2.  Tramadol produces outward currents by activating mu-opioid receptors in adult rat substantia gelatinosa neurones.

Authors:  Akiko Koga; Tsugumi Fujita; Tadahide Totoki; Eiichi Kumamoto
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

3.  Incisional Injury Modulates Morphine Reward and Morphine-Primed Reinstatement: A Role of Kappa Opioid Receptor Activation.

Authors:  Chinwe A Nwaneshiudu; Xiao-You Shi; J David Clark
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

4.  Selective opioid agonist and antagonist competition for [3H]-naloxone binding in amphibian spinal cord.

Authors:  L C Newman; D R Wallace; C W Stevens
Journal:  Brain Res       Date:  2000-11-24       Impact factor: 3.252

5.  A leu-enkephalin depresses transmission from muscle and skin non-nociceptors to first-order feline spinal neurones.

Authors:  E Jankowska; E D Schomburg
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

6.  Differential modulation of kappa and mu opioid antinociception by the glycine/NMDA receptor agonist D-serine.

Authors:  J C Hunter; P Atwal; G N Woodruff; L Singh
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

7.  Contribution of Endogenous Spinal Endomorphin 2 to Intrathecal Opioid Antinociception in Rats Is Agonist Dependent and Sexually Dimorphic.

Authors:  Arjun Kumar; Nai-Jiang Liu; Priyanka A Madia; Alan R Gintzler
Journal:  J Pain       Date:  2015-09-02       Impact factor: 5.820

Review 8.  Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics.

Authors:  Tuan Trang; Ream Al-Hasani; Daniela Salvemini; Michael W Salter; Howard Gutstein; Catherine M Cahill
Journal:  J Neurosci       Date:  2015-10-14       Impact factor: 6.167

9.  The bivalent ligand, MMG22, reduces neuropathic pain after nerve injury without the side effects of traditional opioids.

Authors:  Rebecca Speltz; Mary M Lunzer; Sarah S Shueb; Eyup Akgün; Rachelle Reed; Alex Kalyuzhny; Philip S Portoghese; Donald A Simone
Journal:  Pain       Date:  2020-09-01       Impact factor: 7.926

10.  Inhibition by O-desmethyltramadol of glutamatergic excitatory transmission in adult rat spinal substantia gelatinosa neurons.

Authors:  Akiko Koga; Tsugumi Fujita; Lian-Hua Piao; Terumasa Nakatsuka; Eiichi Kumamoto
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.